By Editorial Panel, Editor, Pharma Business Outlook
The pharmaceutical giant partners with Insitro to use artificial intelligence and biological data to identify new drug targets for complex diseasesLondon, 15 October 2026 – AstraZeneca is strengthenin...
By Editorial Panel, Editor, Pharma Business Outlook
The decision puts another hurdle in the pharmaceutical giant’s race to develop an oral alternative to popular injectable obesity treatmentsNew York, 8 October 2026 – Pfizer has stopped the development...
By Editorial Panel, Editor, Pharma Business Outlook
Novo Nordisk and Anthropic are bringing Claude into research workflows to help scientists explore biological questions and develop new medicines fasterBagsværd, Denmark, 1 October 2026 – Drug discover...
By Editorial Panel, Editor, Pharma Business Outlook
A new pilot program places trained pharmacists at the center of personalized support for customers exploring GLP 1 medicines, nutrition, and healthier routinesBentonville, 17 September 2026 – Walmart...
By Editorial Panel, Editor, Pharma Business Outlook
GenieMD and RxHealing are bringing virtual clinical support into independent pharmacies to help patients manage long-term conditions between doctor visitsSan Francisco, California, 10 September 2026 –...
By Brandon Newman, Founder & CEO, Xevant
By Andrew Brown Ph.D, Chief Commercial Officer, SIRONADX
By August J. Troendle, Chairman & CEO, Medpace
By Ari Bousbib, Chariman & CEO, IQVIA
By Adi Berenson, Co-Founder & CEO, Claire Lab
By Yvonne Lungershausen, CEO, Avance Clinical
By Chris Gilmor, Vice President Sales, Sanner America
Demand for inhaled therapeutics continues to grow steadily. Metered-dose inhalers and dry powder inhalers are the first choice for treating respiratory diseases due to their patient-centered drug deli...
By Ron Lanton III, Sosa Law, Senior Partner: Lanton, Lanton &
Even after a specialty prescription is approved, getting the medicine to the patient can still take time. The pharmacy may be missing a chart note, waiting for benefit verification or an authorization...
By Ben Weintraub, President, inThought Research
Artificial intelligence is touching all parts of our lives, from digital assistants to solving math problems. But we have yet to see a significant impact on the success rate, cost, or development time...
By Dr. Brigham Hyde, Chief Executive Officer, Atropos Health
Healthcare expenditures in the United States represent nearly one in every five dollars spent across the American economy and are showing no signs of slowing down. In a landscape defined by an afforda...
By Ian Speers, MPH, CPH, MedLog, NREMT, Pacto Medical, CEO, Co-Founder and Robert Halvorsen, BE, MIIPS, CTO, Co-Founder,
Moving Beyond Vials and Ampoules: Where to Now? Amidst rapid ongoing advances and innovations in drug discovery and development, pharmaceutical and drug delivery device developers are working fur...
Pharma Business Outlook is more than just a publication—it is a bridge that connects pharmaceutical companies, healthcare providers, and key decision-makers. By fostering discussions on regulatory compliance, emerging market opportunities, and digital transformation, the magazine plays a crucial role in shaping the future of the pharmaceutical ecosystem.
We respect your privacy. The email address you provide will be used solely for subscription purposes and will not be stored or shared.
Subscribe Now